Supportive and precautions
›Non-operative initial care
›Rigid eye shield if ocular injury concern
›No pressure patching
›No topical ointment across suspected laceration without ophthalmology
›Head elevation
›Reduce edema
›Reduce venous congestion
›Cold packs intermittently for 24 to 48 hours
›Soft tissue edema reduction
›Skin protection to prevent frost injury
›Activity precautions
›No nose blowing
›Sneeze with mouth open
›Avoid heavy lifting and Valsalva
›Analgesia and antiemesis
›Acetaminophen oral 1000 mg every 6 hours as needed
›Maximum 4000 mg per day
›Lower maximum in chronic liver disease
›Ibuprofen oral 400 mg every 6 hours as needed
›Avoid in significant bleeding risk
›Avoid in advanced chronic kidney disease
›Ondansetron oral or ODT 4 mg every 8 hours as needed
›QT prolongation risk consideration
›Alternative antiemetic if prolonged QT concern
›Nasal and sinus measures
›Oxymetazoline intranasal 1 to 2 sprays each nostril every 12 hours for up to 3 days
›Avoid prolonged use to prevent rebound congestion
›Caution in severe hypertension
›Saline nasal spray as needed
›Gentle use without forceful sniffing
›Avoid irrigation if CSF leak concern
›Antibiotics
›Selective use strategy
›Consider if open fracture or laceration communicating with sinus
›Consider if gross sinus contamination
›Not routinely required for isolated closed blowout fracture without sinusitis (ACEP Level C, observational data and expert consensus)
›Amoxicillin-clavulanate oral 875 mg every 12 hours for 5 to 7 days
›Alternative if renal impairment
›Counsel for gastrointestinal adverse effects
›Clindamycin oral 300 mg every 6 hours for 5 to 7 days
›Option for penicillin allergy
›C difficile risk counseling
›Tetanus prophylaxis
›Indicated for open wounds per immunization status
›Booster if indicated by wound type and vaccine history
›Tetanus immune globulin if incomplete immunization with high-risk wound
›Orbital compartment syndrome decompression
›Lateral canthotomy and cantholysis pathway
›Indications
›Rapid vision decrease
›Afferent pupillary defect
›Marked proptosis with tight lids
›Intraocular pressure elevation with compatible findings
›Timing principle
›Irreversible ischemic injury risk increases with prolonged optic nerve and retinal ischemia
›Do not delay for imaging when clinical syndrome present (Class I recommendation, expert consensus)
›Post-procedure monitoring
›Repeat visual acuity checks
›Repeat pupillary assessment
›Recheck intraocular pressure if safe
›Ongoing ophthalmology involvement
›Open globe pathway
›Rigid shield and NPO
›Avoid topical drops unless ophthalmology directs
›Avoid pressure and ultrasound
›Antiemesis and analgesia to reduce Valsalva
›Minimize vomiting and coughing
›Gentle handling during transport
›Systemic antibiotics per local open globe protocol
›Broad-spectrum coverage coordinated with ophthalmology
›Timing prioritized before OR when feasible
›Indications for urgent surgical evaluation
›Entrapment with oculocardiac reflex
›Bradycardia with gaze
›Recurrent vomiting triggered by eye movement
›Pediatric trapdoor fracture with entrapment
›Marked motility restriction
›Severe nausea or vomiting
›Minimal external bruising
›Progressive vision deficit with optic canal involvement
›Urgent specialty coordination
›Consideration of decompression based on imaging and exam
›Indications for early elective repair discussion
›Persistent diplopia after swelling improves
›Typically reassessment at 7 to 14 days
›Forced duction findings by specialists
›Large orbital floor defect with enophthalmos risk
›Globe malposition concern
›Cosmetic and functional impact
›Enophthalmos apparent after edema resolution
›Document measurements when feasible
›Shared decision-making with specialist
›Traumatic optic neuropathy therapy uncertainty
›High-dose steroid use not routine due to mixed evidence and adverse effect concerns
›Management individualized with ophthalmology and neurosurgery (ACEP Level C)